Published in Brain Res Bull on January 01, 1986
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
How opioids inhibit GABA-mediated neurotransmission. Nature (1997) 3.09
The lethal effect of mebendazole on secondary Echinococcus granulosus, cysticerci of Taenia pisiformis and tetrathyridia of Mesocestoides corti. Parasitology (1975) 2.97
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A (1987) 2.48
Committee report. Publication recommendations for electrodermal measurements. Psychophysiology (1981) 2.39
Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels. J Biol Chem (1991) 2.18
Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem (1998) 1.73
Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Joint Surg Am (2004) 1.68
Do patients refusing transport remember descriptions of risks after initial advanced life support assessment? Acad Emerg Med (1998) 1.66
Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (1997) 1.57
Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci (1998) 1.54
Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol (2000) 1.43
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol (2001) 1.41
Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA. Neuroscience (1987) 1.41
Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.41
Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol (1990) 1.41
Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol (1996) 1.40
Bicuculline methochloride as a GABA antagonist. Nat New Biol (1972) 1.40
Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (1996) 1.38
Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nat Struct Biol (2000) 1.38
Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of early-stage osteonecrosis. J Bone Joint Surg Am (2005) 1.33
Mutations in the uncE gene affecting assembly of the c-subunit of the adenosine triphosphatase of Escherichia coli. Biochem J (1983) 1.32
Correlation of the findings of magnetic resonance imaging with those of bone biopsy in patients who have stage-I or II ischemic necrosis of the femoral head. J Bone Joint Surg Am (1989) 1.30
The reproducibility of the Childhood Asthma Questionnaires: measures of quality of life for children with asthma aged 4-16 years. Qual Life Res (1994) 1.27
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol (1996) 1.23
Acetabular fractures: long-term follow-up of open reduction and internal fixation. J Orthop Trauma (1994) 1.20
Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.18
Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc Natl Acad Sci U S A (1989) 1.18
Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci (1997) 1.17
Total knee arthroplasty in a group of patients less than 45 years of age. J Arthroplasty (1995) 1.16
Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol (1999) 1.15
Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br J Pharmacol (1999) 1.13
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol (2001) 1.10
Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol (1998) 1.08
The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nat Struct Biol (1997) 1.08
Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem (1975) 1.07
GABA uptake in rat brain slices: inhibition by GABA analogues and by various drugs. J Neurochem (1973) 1.07
The human toxicity of marijuana. Med J Aust (1994) 1.07
Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol Pharmacol (2007) 1.06
Effects of sumatriptan on rat medullary dorsal horn neurons. Pain (2004) 1.03
Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur J Pharmacol (1996) 1.03
Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res (1985) 1.01
Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology (1999) 1.00
Rapid and quantitative blood amino acid analysis by chemical ionization mass spectrometry. Biomed Mass Spectrom (1977) 0.99
Reconstruction of the deficient acetabulum with an oblong prosthesis: three- to seven-year results. J Arthroplasty (1998) 0.98
Retrograde signalling by endocannabinoids. Handb Exp Pharmacol (2005) 0.98
Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br J Pharmacol (2011) 0.97
Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region. Brain Res (1997) 0.97
Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group. Ann Intern Med (1994) 0.97
Isolation of a funnel-web spider polypeptide with homology to mamba intestinal toxin 1 and the embryonic head inducer Dickkopf-1. Toxicon (2000) 0.96
Competitive inhibition of GABA uptake in rat brain slices by some GABA analogues of restricted conformation. J Neurochem (1972) 0.95
Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. J Physiol (2001) 0.95
Detection of occult infection following total joint arthroplasty using sequential technetium-99m HDP bone scintigraphy and indium-111 WBC imaging. J Nucl Med (1988) 0.94
4-aminotetrolic acid: new conformational-restricted analogue of -aminobutyric acid. Nat New Biol (1971) 0.94
The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J Physiol (2003) 0.94
The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes. Br J Pharmacol (2011) 0.93
Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol (1999) 0.93
Electrodermal activity in the 1980s: a review. J R Soc Med (1981) 0.92
Basal palmar skin potential and the electrocardiogram T-wave. Psychophysiology (1971) 0.92
A reliable procedure for comparison of antioxidants in rat brain homogenates. J Pharmacol Toxicol Methods (1998) 0.92
Hyperpolarization by GABAB receptor agonists in mid-brain periaqueductal gray neurones in vitro. Br J Pharmacol (1995) 0.91
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists. Br J Pharmacol (1988) 0.91
Potentiation of enkephalin action by peptidase inhibitors in rat locus ceruleus in vitro. J Pharmacol Exp Ther (1987) 0.91
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke (1999) 0.90
Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci Lett (2000) 0.90
Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release. Eur J Pharmacol (2001) 0.90
Lumbar spinal stenosis and lower extremity arthroplasty. J Arthroplasty (1993) 0.90
Inhibition by adenosine receptor agonists of synaptic transmission in rat periaqueductal grey neurons. J Physiol (1999) 0.89
Kainate-induced apoptosis correlates with c-Jun activation in cultured cerebellar granule cells. J Neurosci Res (1998) 0.89
Sequential indium-labeled leukocyte and bone scans to diagnose prosthetic joint infection. Clin Orthop Relat Res (2000) 0.88
Fishing for drugs from the sea: status and strategies. Trends Pharmacol Sci (1995) 0.88
The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine. Pharmacol Biochem Behav (1999) 0.87
Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens. Brain Res Bull (1988) 0.87
The F1F0-ATPase of Escherichia coli. Substitution of proline by leucine at position 64 in the c-subunit causes loss of oxidative phosphorylation. Biochem J (1983) 0.87
Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary cultures. Neurosci Lett (1997) 0.87
Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. Brain Res (1997) 0.87
Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor. Neurosci Lett (1997) 0.87
Transport of L-[3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors. J Neurochem (1993) 0.86
Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain. Neuropharmacology (2012) 0.86
Tibial tuberosity avulsion fracture in adolescents. J Pediatr Orthop (1981) 0.86
A novel, rapid, computerized method for quantitation of neuronal damage in a rat model of stroke. J Neurosci Methods (2000) 0.86
Isolation and pharmacological characterisation of delta-atracotoxin-Hv1b, a vertebrate-selective sodium channel toxin. FEBS Lett (2000) 0.86
Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model. Br J Pharmacol (2013) 0.86
Discovery and structure of a potent and highly specific blocker of insect calcium channels. J Biol Chem (2001) 0.86
Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795). Neuropharmacology (2001) 0.86
Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels. Mol Pharmacol (2009) 0.85
Bicuculline and GABA-metabolising enzymes. Brain Res (1972) 0.85
Excitatory amino acid projections to the periaqueductal gray in the rat: a retrograde transport study utilizing D[3H]aspartate and [3H]GABA. Neuroscience (1990) 0.85
Neuropharmacology of addiction--setting the scene. Br J Pharmacol (2008) 0.85
Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla. Neuroscience (1998) 0.85
Characterisation of GABA(A) receptors in fetal, neonatal and adult ovine brain: region and age related changes and the effects of allopregnanolone. Neuropharmacology (2000) 0.84
Kainate-induced apoptosis in cultured murine cerebellar granule cells elevates expression of the cell cycle gene cyclin D1. J Neurochem (1998) 0.84
Human Bcl-2 protects against AMPA receptor-mediated apoptosis. J Neurochem (2000) 0.84
Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br J Pharmacol (1999) 0.84